Windlas Biotech Ltd. benchmarking: Perfomance to industry peers

Financial

	Windlas Biotech	Kwality Pharma	Amrutanjan Healthcar
Operational Metrics
Financials
5 yr Average ROE	10.64 %	25.27 %	14.67 %
5yr average Equity Multiplier	1.39	1.96	1.41
5yr Average Asset Turnover Ratio	1.07	1.05	1.22
5yr Avg Net Profit Margin	7.49 %	11.66 %	8.57 %
Price to Book	2.87	5.43	4.34
P/E	22.98	27.85	26.09
5yr Avg Cash Conversion Cycle	-12.87 Days	55.02 Days	21.59 Days
Inventory Days	39.91 Days	67.04 Days	23.18 Days
Days Receivable	72.81 Days	132.46 Days	51.48 Days
Days Payable	93.99 Days	126.93 Days	49.13 Days
5yr Average Interest Coverage Ratio	42.87	16.13	27.21
5yr Avg ROCE	16.39 %	34.73 %	24.07 %
5yr Avg Operating Profit Margin	12.11 %	23.23 %	14.15 %
5 yr average Debt to Equity	0.05	0.46	0.12
5yr CAGR Net Profit	30.97 %	21.34 %	16.38 %
5yr Average Return on Assets	7.71 %	12.96 %	10.59 %
Shareholdings
Promoter Holding	61.99 %	54.83 %	46.52 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	1.24 %	0.38 %	-3.5 %
Change in Mutual Fund Holding (3 Yrs)	-4.76 %	0.0	1.41 %

	Windlas Biotech	Kwality Pharma	Amrutanjan Healthcar
Product Wise Break-Up	Product Wise Break-Up CDMO 72.07 Trade Generics & OTC 23.42 Exports 4.5 Women Hygiene 0 Beverages 0 OTC Products 0 Others 0.01	-	Product Wise Break-Up OTC 67.98 CDMO 0 Exports 0 Beverages 3.64 Women Hygiene 27.85 Trade Generics & OTC 0 Others 0.53
Location Wise Break-Up	Location Wise Break-Up India 95.68 India 0 Rest of the World 0 North India 0 East India 0 West India 0 South India 0 Others 4.32	Location Wise Break-Up North India 0 India 47.21 West India 0 Rest of the World 0 South India 0 East India 0 Others 52.79	Location Wise Break-Up North India 4.0 India 0 West India 12.0 Rest of the World 0 South India 58.0 East India 26.0
Acute vs Chronic	Acute vs Chronic Chronic & Sub-Chronic 59.0 Acute 41.0	-	-
Segment Wise Break-Up	Segment Wise Break-Up Pharmaceutical 100.0	-	-